MRK

Merck & Co
D

MRK

Arincen67/100B

Merck & Co balance sheet 1985–2026

Merck & Co had 9.65B USD in cash and short-term investments on 30 September 2026, against total debt of 53.78B USD: net debt of 44.13B USD.

Total assets Total liabilities Shareholders' equity

Click a line's chart icon in the table to add it to the chart; hover over it for a quick look.

Fiscal year
Latest
Q3 FY2026
FY2025
31 Dec 2025
FY2024
31 Dec 2024
FY2023
31 Dec 2023
FY2022
31 Dec 2022
FY2021
31 Dec 2021
FY2020
31 Dec 2020
FY2019
31 Dec 2019
FY2018
31 Dec 2018
FY2017
31 Dec 2017
FY2016
31 Dec 2016
Cash and equivalents
9.55B14.57B13.24B6.84B12.69B8.10B8.05B9.68B7.97B6.09B6.52B
Short-term investments
100.00M0.00447.00M252.00M498.00M0.000.00774.00M899.00M2.41B7.83B
9.65B14.57B13.69B7.09B13.19B8.10B8.05B10.45B8.86B8.50B14.34B
Cash growth
-47.02%+6.40%+92.99%-46.23%+62.94%+0.57%-22.97%+17.89%+4.31%-40.74%+6.81%
Receivables
12.74B12.68B10.28B10.35B9.45B9.23B6.80B6.78B7.07B6.87B7.02B
Inventory
6.16B6.66B6.11B6.36B5.91B5.95B5.55B5.98B5.44B5.10B4.87B
Other current assets
10.38B9.49B8.71B8.37B7.17B6.99B7.36B4.28B4.50B4.30B4.39B
Total current assets
38.94B43.52B38.78B32.17B35.72B30.27B27.76B27.48B25.88B24.77B30.61B
Property, plant and equipment
25.90B26.82B23.78B23.05B21.42B19.28B17.00B15.05B13.29B12.44B12.03B
Long-term investments
1.60B2.24B463.00M252.00M1.02B370.00M785.00M1.47B6.23B12.13B11.42B
Goodwill and intangibles
46.43B48.26B38.04B39.21B41.47B44.20B32.98B33.62B31.36B32.47B35.47B
Goodwill
21.95B21.58B21.67B21.20B21.20B21.26B18.88B19.43B18.25B18.28B18.16B
Intangible assets
24.48B26.68B16.37B18.01B20.27B22.93B14.10B14.20B13.10B14.18B17.31B
Other non-current assets
19.90B16.03B16.04B12.00B9.53B11.58B13.06B6.77B5.88B6.08B5.85B
Total assets
132.77B136.87B117.11B106.68B109.16B105.69B91.59B84.40B82.64B87.87B95.38B
Accounts payable
5.03B4.40B4.08B3.92B4.26B4.61B4.33B3.74B3.32B3.10B2.81B
Deferred revenue
0.000.000.000.000.000.000.000.000.000.000.00
Short-term debt
4.09B2.88B2.65B1.37B1.95B2.41B6.43B3.61B5.31B3.06B568.00M
Other current liabilities
6.44B14.09B-282.00M-285.00M-281.00M-304.00M795.00M0.000.000.000.00
Total current liabilities
28.80B28.33B28.42B25.69B24.24B23.87B27.33B22.22B22.21B18.61B17.20B
Long-term debt
49.69B46.75B34.46B33.68B28.75B30.69B25.36B22.74B19.81B21.35B24.27B
Other non-current liabilities
7.88B6.79B5.59B7.86B7.31B8.21B11.16B11.20B12.04B11.12B8.51B
Lease obligations, current
0.000.00282.00M285.00M281.00M304.00M291.00M0.000.000.000.00
Lease obligations, long-term
0.00901.00M877.00M928.00M1.01B1.23B1.34B768.00M0.000.000.00
Total liabilities
87.83B84.20B70.73B69.04B63.10B67.44B66.18B58.40B55.76B53.30B55.07B
Common stock and paid-in capital
1.79B1.79B1.79B1.79B1.79B1.79B1.79B1.79B1.79B1.79B1.79B
Retained earnings
66.22B73.08B63.07B53.90B61.08B53.70B47.36B46.60B42.58B41.35B44.13B
Accumulated other comprehensive income
-3.89B-4.29B-4.95B-5.16B-4.77B-4.43B-6.63B-6.19B-5.55B-4.91B-5.23B
Shareholders' equity
44.89B52.61B46.31B37.58B45.99B38.18B25.32B25.91B26.70B34.34B40.09B
Minority interest
53.00M56.00M59.00M54.00M67.00M73.00M87.00M94.00M181.00M233.00M220.00M
53.78B50.53B38.27B36.27B31.99B34.63B33.42B27.35B25.11B24.41B24.84B
Net cash
-44.13B-35.97B-24.58B-29.18B-18.79B-26.54B-25.37B-16.90B-16.25B-15.91B-10.50B
Working capital
10.14B15.19B10.36B6.47B11.48B6.39B437.00M5.26B3.67B6.15B13.41B
Book value per share
18.1220.9818.2314.7618.0915.049.9610.049.9712.4914.38
Tangible book value
-1.53B4.35B8.28B-1.63B4.52B-6.01B-7.67B-7.71B-4.66B1.87B4.62B
Tangible book value per share
-0.621.733.26-0.641.78-2.37-3.02-2.99-1.740.681.66
Current ratio
1.351.541.361.251.471.271.021.241.171.331.78
Debt to equity
1.200.960.830.970.700.911.321.060.940.710.62

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

Common questions about Merck & Co's cash and debt

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.